Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 Feb 10;1(5849):328–330. doi: 10.1136/bmj.1.5849.328

Abnormal Excretion of Corticosteroid Sulphates in Patients with Breast Cancer

P C Ghosh, E Lockwood, G W Pennington
PMCID: PMC1588192  PMID: 4685623

Abstract

In a preliminary study, the 24-hour urinary excretion of corticosteroid sulphates and free cortisol have been measured in a group of patients with breast cancer and compared with the excretion of the same compounds in a group of normal women of similar age. Excretion of corticosteroid sulphates in the breast cancer group was found to be markedly raised. In a small number of patients with localized cancer of sites other than the breast the level of corticosteroid sulphate was not raised. If proved metastases were present a noticeable rise was observed.

Full text

PDF
328

Images in this article

330p330-a
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLEN B. J., HAYWARD J. L., MERIVALE W. H. The excretion of 17-ketosteroids in the urine of patients with generalised carcinomatosis secondary to carcinoma of the breast. Lancet. 1957 Mar 9;272(6967):496–499. doi: 10.1016/s0140-6736(57)90669-4. [DOI] [PubMed] [Google Scholar]
  2. BULBROOK R. D., GREENWOOD F. C., HAYWARD J. L. Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. Lancet. 1960 May 28;1(7135):1154–1157. doi: 10.1016/s0140-6736(60)91040-0. [DOI] [PubMed] [Google Scholar]
  3. BULBROOK R. D., HAYWARD J. L., SPICER C. C., THOMAS B. S. A comparison between the urinary steroid excretion of normal women and women with advanced breast cancer. Lancet. 1962 Dec 15;2(7268):1235–1237. doi: 10.1016/s0140-6736(62)92811-8. [DOI] [PubMed] [Google Scholar]
  4. BULBROOK R. D., HAYWARD J. L., SPICER C. C., THOMAS B. S. Abnormal excretion of urinary steroids by women with early breast cancer. Lancet. 1962 Dec 15;2(7268):1238–1240. doi: 10.1016/s0140-6736(62)92812-x. [DOI] [PubMed] [Google Scholar]
  5. BULBROOK R. D., HAYWARD J. L., THOMAS B. S. THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY. Lancet. 1964 May 2;1(7340):945–947. doi: 10.1016/s0140-6736(64)91741-6. [DOI] [PubMed] [Google Scholar]
  6. DESHPANDE N., HAYWARD J. L., BULBROOK R. D. PLASMA 17-HYDROXYCORTICOSTEROIDS AND 17-OXOSTEROIDS IN PATIENTS WITH BREAST CANCER AND IN NORMAL WOMEN. J Endocrinol. 1965 May;32:167–177. doi: 10.1677/joe.0.0320167. [DOI] [PubMed] [Google Scholar]
  7. Ghosh P. C., Lockwood E., Pennington G. W. The use of competitive protein binding in the assay of corticosteroids and their assessment throughout a menstrual cycle. Steroidologia. 1971;2(5):289–295. [PubMed] [Google Scholar]
  8. Hsu T. H., Bledsoe T. Measurement of urinary free corticoids by competitive protein-binding radioassay in hypoadrenal states. J Clin Endocrinol Metab. 1970 Apr;30(4):443–448. doi: 10.1210/jcem-30-4-443. [DOI] [PubMed] [Google Scholar]
  9. Kolanowski J., Pizarro M. A. Critical evaluation of competitive protein-binding radioassay for cortisol. Ann Endocrinol (Paris) 1969;30(Suppl):177–182. [PubMed] [Google Scholar]
  10. Kumaoka S., Sakauchi N., Abe O., Kusama M., Takatani O. Urinary 17-ketosteroid excretion of women with advanced breast cancer. J Clin Endocrinol Metab. 1968 May;28(5):667–672. doi: 10.1210/jcem-28-5-667. [DOI] [PubMed] [Google Scholar]
  11. Salih H., Flax H., Hobbs J. R. In-vitro oestrogen sensitivity of breast-cancer tissue as a possible screening method for hormonal treatment. Lancet. 1972 Jun 3;1(7762):1198–1202. doi: 10.1016/s0140-6736(72)90923-3. [DOI] [PubMed] [Google Scholar]
  12. Sneddon A., Steel J. M., Strong J. A. Effect of thyroid funtion and of obesity on discriminant function for mammary carcinoma. Lancet. 1968 Oct 26;2(7574):892–894. doi: 10.1016/s0140-6736(68)91056-8. [DOI] [PubMed] [Google Scholar]
  13. Wade A. P., Tweedie M. C., Davis J. C., Clarke C. A., Haggart B. The discriminant function in early carcinoma of the breast. Lancet. 1969 Apr 26;1(7600):853–857. doi: 10.1016/s0140-6736(69)91899-6. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES